The largest community of pharma leaders

Bayer Continues to Earn Top Marks in 2020 Corporate Equality Index

WHIPPANY, N.J.–()–For the third consecutive year, Bayer U.S. received a perfect score of 100 percent on the 2020 Corporate Equality Index (CEI), the nation’s premier benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality, administered by the Human Rights Campaign (HRC) Foundation.

“We are so proud to be recognized year after year by the HRC,” said Phil Blake, President of Bayer U.S. “This nationwide survey and report showcases our commitment to fostering, cultivating and preserving a culture of inclusion. Creating an environment where our employees are able to fulfill their full potential, while harnessing their diverse backgrounds, perspectives and experiences, makes us stronger.”

Bayer offers a variety of resources and benefits that provide an inclusive work environment, such as transgender-inclusive health care coverage, parity between same- and different-sex couple benefits, external advocacy for LGBT+ equality, and ally educational programs.

One vital part of the company’s diversity and inclusion efforts is its employee resource groups. In particular, BLEND, Bayer’s global community for lesbian, gay, straight, bisexual and transgender employees and their allies, provides a voice to colleagues and advocates for openness and respect for all employees.

“In our time with the company holding various roles in different divisions, we can both attest to Bayer’s commitment to inclusion and diversity,” said Rich Shields and Bonnie Finger, BLEND’s U.S. Co-Leads for Bayer. “This rating by HRC is evidence of that commitment. We both have examples in our respective organizations where inclusive policies and procedures go beyond just words about hiring or benefits and create an inclusive culture for LGBT+ employees, truly making Bayer a great place to work.”

The 2020 CEI evaluates each company within five broad categories, including LGBTQ-related policies and practices, employment benefits, competency programs and public engagement with the LGBTQ community. Bayer’s efforts in satisfying all of the CEI’s criteria earned a 100 percent ranking and the designation as a Best Place to Work for LGBTQ Equality.

“The impact of the Human Rights Campaign’s Corporate Equality Index over its 18-year history is profound,” said HRC President Alphonso David. “In this time, the corporate community has worked with us to adopt LGBTQ-inclusive policies, practices and benefits, establishing the Corporate Equality Index as a primary driving force for LGBTQ workplace inclusion in America and across the globe.”

For more information on the 2020 Corporate Equality index, or to download a free copy of the report, visit

The Human Rights Campaign Foundation is the educational arm of America’s largest civil rights organization working to achieve equality for lesbian, gay, bisexual transgender and queer people. HRC envisions a world where LGBTQ people are embraced as full members of society at home, at work and in every community.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to

Social Media Channels
– Facebook: BayerUnitedStates
– Twitter: BayerUS
– Instagram: BayerUS
– YouTube: BayerUS

Bayer® and the Bayer Cross® are registered trademarks of Bayer.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


Recent Articles